Thompson Davis & Co’s VivoSim Labs VIVS Stock Holding History

Thompson Davis & Co’s Portfolio VIVS Stock Details VIVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-1	Closed	-$3K	–	865
2013 Q4	$3K	Buy	+1	New	+$1.96K	﹤0.01%	631

Other funds holding VIVS

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return

Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Thompson Davis & Co's VIVS Position: Q1 2014 in Review

Thompson Davis & Co sold out of VivoSim Labs (VIVS) in Q1 2014, closing a stake of 1 share — an estimated $3K sold.

Thompson Davis & Co first reported a position in VIVS in Q4 2013 and held it in 1 quarter. The position peaked at $3K in Q4 2013. 94 funds tracked by Wall St. Rank hold VIVS as of Q1 2014.

Thompson Davis & Co reported no remaining VivoSim Labs position as of Q1 2014 after selling out during the quarter.
Thompson Davis & Co sold 1 VivoSim Labs share in Q1 2014, an estimated $3K.
Thompson Davis & Co first reported a position in VivoSim Labs in Q4 2013 and held it in 1 quarter.
Thompson Davis & Co's VivoSim Labs position peaked at $3K in Q4 2013.
94 funds tracked by Wall St. Rank held VivoSim Labs as of Q1 2014.

Based on Thompson Davis & Co's 13F filing for Q1 2014, filed 9 May 2014.